Philippines - English - FDA (Food And Drug Administration)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), panleucopenia virus (pli iv) and inactivated calicivirus (fcv 431) and (fcv g1 strains) - suspension for injection (sc) - 1 dose of 1 ml or 0.5 ml contains attenuated feline rhinotracheitis herpesvirus(fhv f2 strain)≥104.9 ccid50; inactivated feline calicivirus (fcv 431 and fcv g1 strains) antigens≥ 2.0 elisa u.; attenuated feline panleucopenia virus (pli iv) ≥103.5 ccid50

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - feline calici virus (attenuated); feline panleucopenia virus (attenuated); feline rhinotracheitis virus (attenuated) - feline calici virus (attenuated) 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine; feline rhinotracheitis virus (attenuated) 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - feline rhinotracheitis virus (attenuated); feline panleucopenia virus (attenuated); feline calici virus (attenuated) - feline rhinotracheitis virus (attenuated) 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine; feline calici virus (attenuated) 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

virbac new zealand limited - feline panleucopenia virus (attenuated); feline calici virus (attenuated); feline rhinotracheitis virus (attenuated) - feline panleucopenia virus (attenuated) 0 vaccine; feline calici virus (attenuated) 0 vaccine; feline rhinotracheitis virus (attenuated) 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - feline rhinotracheitis virus (attenuated); feline calici virus (attenuated); chlamydia psittaci; feline panleucopenia virus (attenuated) - feline rhinotracheitis virus (attenuated) 0 vaccine; feline calici virus (attenuated) 0 vaccine; chlamydia psittaci 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health ltd - feline chlamydia psittaci strain baker; feline calici virus (attenuated); feline panleucopenia virus (attenuated); feline rhinotracheitis virus (attenuated) - feline chlamydia psittaci strain baker 0 vaccine; feline calici virus (attenuated) 0 vaccine; feline panleucopenia virus (attenuated) 0 vaccine; feline rhinotracheitis virus (attenuated) 0 vaccine - vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

elanco animal health, eli lilly and company limited - feline enteritis (panleucopenia) virus (fpv), snow leopard strain live attenuated, feline rhinotracheitis virus (fvr), strain fvrm live attenuated, feline calicivrus, strain f9 live attenuated - lyophilisate and solvent for solution for injection - unknown - feline panleucopenia virus / parvovirus vaccine + feline rhinotracheitis virus vaccine + feline cal - feline - immunological - live vaccine

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs.onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals for felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease.onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.